InnovAge Holding Corp. reported its financial results for the fourth quarter and fiscal year ended June 30, 2025.
The company experienced a strong year with responsible growth, financial discipline, and clinical performance.
CEO Patrick Blair expressed confidence in the progress made during Fiscal 2025 and anticipates continued momentum in Fiscal 2026.
Financial Performance Growth
Total revenue increased by approximately 11.8% to $853.7 million compared to the previous year.
Loss Before Income Taxes
The Loss Before Income Taxes for Fiscal Year 2025 was $34.0 million, a 56.0% increase from the previous year.
Net Loss Margin
The net loss margin in 2025 was 4.1%, a 1.1 percentage point increase from the previous year.
Adjusted EBITDA Increase
Adjusted EBITDA saw a significant increase to $34.5 million, up $18.0 million from 2024.
- The company's total revenue growth of 11.8% reflects strong performance and market demand for its healthcare programs.
- The increase in Loss Before Income Taxes and Net Loss Margin indicates the company's focus on strategic financial management.
- The substantial rise in Adjusted EBITDA demonstrates improved operational efficiency and cost control measures.
InnovAge Holding Corp. has shown impressive financial results for Fiscal Year 2025, with significant growth in revenue and improvements in key financial metrics. The company's strong performance and strategic outlook for Fiscal 2026 position it for continued success in the industry.